Results 31 to 40 of about 2,680 (197)

AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant Acinetobacter nosocomialis

Frontiers in Microbiology, 2020
Carbapenem-resistant Acinetobacter nosocomialis (CRAn) is a significant public health concern. Tigecycline non-susceptible CRAn (Tn-CRAn) isolates have emerged worldwide.
Yi-Tzu Lee, Yi-Tzu Lee, Hsing-Yu Chen, Ya-Sung Yang, Yu-Ching Chou, Tein-Yao Chang, Wei-Jane Hsu, I-Chieh Lin, ACTION Study Group, Jun-Ren Sun   +9 more
doaj   +1 more source

1243. Eravacycline in Bacteremia: A Case Series [PDF]

Open Forum Infectious Diseases, 2021
Abstract Background Eravacycline (ERV) is FDA-approved for the treatment of complicated intra-abdominal infections, but there is limited experience for non-FDA approved indications. Methods We present five cases that utilized ERV for ...
Andrade, Justin A, Kosalka, Robert, Truong, James, Rosenberg, Joshua R   +3 more
openaire   +1 more source

In Vitro Activities of Aztreonam-Avibactam, Eravacycline, Cefoselis, and Other Comparators against Clinical Enterobacterales Isolates: a Multicenter Study in China, 2019

Microbiology Spectrum, 2023
Aztreonam-avibactam, eravacycline, and cefoselis are three novel antimicrobial agents for the treatment of serious infections caused by Gram-negative bacteria. We evaluated the in vitro activities of the above-mentioned three antimicrobial agents against
Jiawei Chen, Yong Liu, Wei Jia, Xuesong Xu, Guizhen Sun, Tong Wang, Jin Li, Ge Zhang, Ran Jing, Hongli Sun, Yingchun Xu, Yali Liu   +11 more
doaj   +1 more source

Management of KPC-Producing Klebsiella pneumoniae Infections [PDF]

, 2015
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic ...
M. Bassetti, D.R. Giacobbe, H. Giamarellou, C. Viscoli, G.L. Daikos, G. Dimopoulos, F.G. De Rosa, E.J. Giamarellos-Bourboulis, G.M. Rossolini, E. Righi, I. Karaiskos, M. Tumbarello, D.P. Nicolau, P.L. Viale, G. Poulakou, Rossolini, Munoz-Price, Grundmann, Maltezou, Giacobbe, Banerjee, Girmenia, Patel, Bauer, Arena, Kostrzewa, Rotova, Gaibani, Hoyos-Mallecot, Salimnia, Vincent, Arena, Paul, Zusman, Dickstein, Tzouvelekis, Tumbarello, Tumbarello, Daikos, Gutiérrez-Gutiérrez, Del Bono, Pea, Tenover, Clinical and Laboratory Standards Institute (CLSI), Nation, Capone, Monaco, Giacobbe, Giamarellou, Spyropoulou, Meletis, Karaiskos, Karaiskos, Sorlí, Sandri, Nation, Gonzalez-Padilla, Machuca, Stankowicz, Poulakou, Bassetti, Montravers, Bassetti, Ramirez, Wiskirchen, Giamarellou, Pontikis, Parker, Albiero, Lepak, Docobo-Pérez, Grabein, Shields, Temkin, Shields, Shields, Perez, Bulik, Giamarellou, Souli, Oliva, Cprek, Poulakou, Lu, Karvouniaris, Kollef, Rello, Solé-Lleonart, Palmer, Kalil, Monogue, Berthoin, Pea, Lorente, Ho, Kim, Keel, Martínez, Patel, Zarkotou, Falcone, Nguyen, de Oliveira, Dimopoulos, Chastre, Capellier, Havey, Matthaiou, Tacconelli, De Rosa, Sypsa, Gagliotti, Lin, Giacobbe, Munoz-Price, Tofteland, Schwaber, Lerner, De Rosa, Abdallah, Tumbarello, Giannella, Giannella, Giacobbe, Salsano, Sbrana, Girmenia, De Rosa, Forcina, Viale, Zuckerman, Saidel-Odes, Lübbert, Tascini, Oren, Tascini, Machuca, Bassetti, Falagas, Sutcliffe, Connors, Zhang, Solomkin   +142 more
core   +2 more sources

Global shortage of neonatal and paediatric antibiotic trials: rapid review. [PDF]

, 2017
OBJECTIVES: There have been few clinical trials (CTs) on antibiotics that inform neonatal and paediatric drug labelling. The rate of unlicensed and off-label prescribing in paediatrics remains high.
Barker, CI, Bielicki, JA, Bradley, JS, Folgori, L, Lutsar, I, Sharland, M, Thompson, G   +6 more
core   +4 more sources

Is Medical Research Informing Professional Practice More Highly Cited? Evidence from AHFS DI Essentials in Drugs.com [PDF]

, 2017
This is an accepted manuscript of an article published by Springer in Scientometrics on 21/02/2017, available online: https://doi.org/10.1007/s11192-017-2292-3 The accepted version of the publication may differ from the final published version.Citation ...
BI Hutchins, D Barbic, D Kryl, D Solla Price de, EC Fieller, F Narin, G Lewison, G Lewison, H Small, J Grant, J Grant, Kayvan Kousha, L Waltman, L Waltman, M Thelwall, M Thelwall, M Thelwall, M Thelwall, M Thelwall, M Thelwall, M Thelwall, Mahshid Abdoli, ME Feder, Mike Thelwall, MM Scarlat, R Schekman, T Jefferson, T Jefferson, É Archambault   +28 more
core   +1 more source

Eravacycline infusion–related hypoesthesia: A case report

American Journal of Health-System Pharmacy, 2022
Abstract Purpose Eravacycline (ERV) is often used for drug-resistant gram-negative and nontuberculous mycobacteria (NTM) infections, but infusion site reactions are a potential adverse effect. We report a case of severe hypoesthesia secondary to ERV infusion.
R Briley, Miller, Kinsey M, McClure, Robby G, Stewart, Stephanie C, Shealy, Krishnan, Brown, P Brandon, Bookstaver   +5 more
openaire   +2 more sources

Recurrent spontaneous Escherichia coli meningitis in an adult: a case report [PDF]

, 2023
Objectives The aim of this study was to characterize an unusual case of spontaneous, community-acquired Escherichia coli meningitis in an adult presenting to a general hospital in Kenya, where initial clinical recovery was followed by reinfection with an
Aliyan, Nadia A, Amulele, Anne V, Arara, Alfred M, Berkley, James A, Etyang, Anthony, Gordon, Nicola C, Machanja, Edwin W, Ong'ayo, Gerald, Wareham, David W   +8 more
core   +2 more sources

Moxifloxacin in Pediatric Patients With Complicated Intra-abdominal Infections: Results of the MOXIPEDIA Randomized Controlled Study [PDF]

, 2018
Background: This study was designed to evaluate primarily the safety and also the efficacy of moxifloxacin (MXF) in children with complicated intraabdominal infections (cIAIs). Methods: In this multicenter, randomized, double-blind, controlled study, 451
Criollo, Margarita, DiCasoli, Carl, Digtyar, Valeri, Emil, Sherif G. S., Engelis, Arnis, Grossmann, Ulrike, Nkulikiyinka, Richard, Stass, Heino, Willmann, Stefan, Wirth, Stefan   +9 more
core   +1 more source

Real-world, multicentre evaluation of the incidence and risk factors for non-susceptible Stenotrophomonas maltophilia isolates [PDF]

, 2022
Background: Stenotrophomonas maltophilia is a cause of infection most commonly in the opportunistic host. Trimethoprim-sulfamethoxazole and levofloxacin are considered first-line treatment agents. With reports of increasing resistance to these first-line
Bookstaver, P. Brandon, Chastain, Daniel B., Jones, Bruce M., Wagner, Jamie L.   +3 more
core   +2 more sources